PMV Pharmaceuticals, Inc.
PMVP
$1.48
$0.010.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.67% | 13.69% | 11.02% | -15.39% | -9.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.89% | 16.41% | 5.88% | -4.63% | -7.08% |
| Operating Income | -19.89% | -16.41% | -5.88% | 4.63% | 7.08% |
| Income Before Tax | -27.57% | -21.62% | -8.48% | 6.86% | 12.26% |
| Income Tax Expenses | 86.90% | -609,966.67% | -536,733.33% | -402,600.00% | -323,380.00% |
| Earnings from Continuing Operations | -65.45% | 6.49% | 14.87% | 29.06% | 34.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.45% | 6.49% | 14.87% | 29.06% | 34.07% |
| EBIT | -19.89% | -16.41% | -5.88% | 4.63% | 7.08% |
| EBITDA | -21.57% | -17.57% | -6.12% | 5.28% | 8.08% |
| EPS Basic | -61.45% | 11.14% | 21.28% | 35.95% | 40.40% |
| Normalized Basic EPS | -26.18% | -16.74% | 0.42% | 16.66% | 21.75% |
| EPS Diluted | -61.45% | 11.14% | 21.28% | 35.95% | 40.40% |
| Normalized Diluted EPS | -26.18% | -16.74% | 0.42% | 16.66% | 21.75% |
| Average Basic Shares Outstanding | 1.96% | 4.62% | 7.44% | 10.49% | 11.18% |
| Average Diluted Shares Outstanding | 1.96% | 4.62% | 7.44% | 10.49% | 11.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |